Fatty liver disease (MASLD/MASH): open trials in Poland

13 open trials have a site in Poland. Registry data; only the trial team decides who can take part.

NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Częstochowa · Gdansk · Gdynia · Katowice · Krakow · Lodz · Poznan · Warsaw · Wroclaw
Registry updated 2026-11-06
NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Krakowskie Centrum Medyczne Sp. z o.o., Cracow · Santa SP. z o.o, Lodz · Futuremeds Sp. z o.o., Lodz · Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie, Lublin · ID Clinic, Myslowice · Bodyclinic sp. z o.o. sp.k., Warsaw · Futuremeds Sp. z o.o., Warsaw · Futuremeds Sp. z o.o., Wroclaw · EMC Instytut Medyczny S.A., Wroclaw
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Futuremeds Sp. z o.o., Cracow · Futuremeds Sp. z o.o., Lodz · Santa SP. z o.o, Lodz · Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie, Lublin · ID Clinic, Myslowice · Futuremeds Sp. z o.o., Warsaw · Bodyclinic sp. z o.o. sp.k., Warsaw · Futuremeds Sp. z o.o., Wroclaw · EMC Instytut Medyczny S.A., Wroclaw
Registry updated 2026-10-28
2024-512895-36-00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Trial Treatment · Phase 3 · Akero Therapeutics Inc.
Futuremeds Sp. z o.o., Cracow · Synexus Polska Sp. z o.o., Czestochowa · Synexus Polska Sp z o.o., Gdansk · Synexus Polska Sp. z o.o., Katowice · Synexus Polska Sp. z o.o., Lodz · Synexus Polska Sp z o o, Poznan · Synexus Polska Sp. z o.o., Warsaw · Futuremeds Sp. z o.o., Warsaw · Futuremeds Sp. z o.o., Wroclaw · Synexus Polska Sp. z o.o., Wroclaw
Registry updated 2026-10-23
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Futuremeds Sp. z o.o., Cracow · Futuremeds Sp. z o.o., Lodz · Santa SP. z o.o, Lodz · ID Clinic Arkadiusz Pisula, Myslowice · MTZ Clinical Research powered by Pratia, Warsaw · Medical Network Sp z o o, Warsaw · Futuremeds Sp. z o.o., Warsaw · Futuremeds Sp. z o.o., Wroclaw
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Futuremeds Sp. z o.o., Cracow · Santa SP. z o.o, Lodz · Futuremeds Sp. z o.o., Lodz · ID Clinic Arkadiusz Pisula, Myslowice · Medical Network Sp z o o, Warsaw · MTZ Clinical Research powered by Pratia, Warsaw · Futuremeds Sp. z o.o., Wroclaw
Registry updated 2026-10-23
2026-525755-82-00
A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)
Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie, Cracow · ID Clinic Arkadiusz Pisula, Myslowice · Solumed Centrum Medyczne Sp. z o.o., Poznan · Medical Network Sp z o o, Warsaw
Registry updated 2026-10-19
2026-525757-37-00
A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)
Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie, Cracow · ID Clinic Arkadiusz Pisula, Myslowice · Solumed Centrum Medyczne Sp. z o.o., Poznan · Medical Network Sp z o o, Warsaw
Registry updated 2026-10-19
NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Częstochowa · Gdansk · Katowice · Krakow · Lodz · Poznan · Warsaw · Wroclaw
Registry updated 2026-10-13
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Kresmed Sp. z o. o., Bialystok · Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk · Centrum Medyczne Pratia Katowice, Katowice · Gyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero, Katowice · Santa Familia Ptg Lodz, Lodz · ID Clinic, Mysłowice · Uniwersyteckie Centrum Stomatologii i Medycyny Specjalistycznej, Poznan · Private Practice - Dr. Lukasz Krupa, Rzeszów · Panstwowy Instytut Medyczny Mswia, Warsaw · Szpital Czerniakowski, Warsaw · Przychodnie Care Access, Warsaw · MTZ Clinical Research powered by Pratia, Warsaw · Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś, Warsaw · NZOZ GynCentrum - Oddział Warszawa, Warsaw · ETG Zamosc, Zamość
Registry updated 2026-10-08
NCT07221188
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Trial Treatment · Phase 3 · GlaxoSmithKline
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie, Cracow · Pratia S.A., Katowice · Gyncentrum Sp. z o.o., Katowice · Amicare Sp. z o.o. S.K., Lodz · Santa SP. z o.o, Lodz · Medrise Sp. z o.o., Lublin · ID Clinic Arkadiusz Pisula, Myslowice · Solumed Centrum Medyczne Sp. z o.o., Poznan · Medical Network Sp z o o, Warsaw · Melita Medical Sp. z o.o., Wroclaw
Registry updated 2026-09-17
2023-505141-48-00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Trial Treatment · Phase 3 · Akero Therapeutics Inc.
Krakowskie Centrum Medyczne Sp. z o.o., Cracow · Synexus Polska Sp. z o.o., Czestochowa · Synexus Polska Sp z o.o., Gdansk · Synexus Polska Sp. z o.o., Gdynia · Synexus Polska Sp. z o.o., Katowice · Pratia S.A., Katowice · Synexus Polska Sp. z o.o., Lodz · Synexus Polska Sp z o o, Poznan · Futuremeds Sp. z o.o., Warsaw · Synexus Polska Sp. z o.o., Warsaw · Medical Network Sp z o o, Warsaw · Synexus Polska Sp. z o.o., Wroclaw · Futuremeds Sp. z o.o., Wroclaw
Registry updated 2026-01-22
NCT07336563
ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study
Research · Jarosław Drobnik
ENDOCARE, Wroclaw
Registry updated 2026-01-15

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error